- Mixed dyslipidemia. First portion. Lipid Quartet, atherogenic lipids2011 | Second Faculty of Medicine
- Mixed dyslipidemia. Second portion. Associated diseases like 2 diabetes mellitus type, obesity, cardiovascular disease2011 | Second Faculty of Medicine
- Severe mixed dyslipidemia as a manifestation of hematological disease: case report2019 | First Faculty of Medicine, Central Library of Charles University
- Mixed dyslipidemia. Third portion. Prevention and therapy recommendations2011 | Second Faculty of Medicine
- Combined therapy of mixed dyslipidemia in patients with high cardiovascular risk and changes in the lipid target values and atherogenic index of plasma2014 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Výsledky léčby kombinované terapie statinem a fibrátem u nemocných se smíšenou dyslipidemií2007 | Faculty of Medicine in Pilsen
- Výsledky léčby kombinované terapie statin a fibrát u nemocných se smíšenou dyslipidemií2007 | Faculty of Medicine in Pilsen
- The effect of treatment with fenofibrate on the risk profile of patients with metabolic syndrome and mixed dyslipidemia treated on an outpatient basis2007 | Faculty of Medicine in Pilsen
- The effect of treatment with fenofibrate on the risk profile of patients with metabolic syndrome and mixed dyslipidemia treated on an outpatient basis2007 | First Faculty of Medicine
- The effect of treatment with fenofibrate on the risk profile of patients with metabolic syndrome and mixed dyslipidemia treated on an outpatient basis2007 | Faculty of Physical Education and Sport
- The effect of treatment with fenofibrate on the risk profile of patients with metabolic syndrome and mixed dyslipidemia treated on an outpatient basis2007 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Combination of lipid-lowering drugs: how to continue after the ACCORD trial?2010 | First Faculty of Medicine
- A patient with high cardiovascular risk from the view of Czech Institute of Metabolic Syndrome2007 | Faculty of Medicine in Pilsen
- A comparison of generic and semigeneric atorvastatin effectivity2005 | First Faculty of Medicine
- A patient with high cardiovascular risk from the view of Czech Institute of metabolic syndrome2007 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- How to choose antihypertensive therapy in patients with metabolic syndrome2010 | First Faculty of Medicine
- Obesity as a disease. First share. Etiology and pathogenesis, consequences and associated diseases, prevention and therapy2011 | Second Faculty of Medicine
- Evolocumab významně snížil hladinu LDL cholesterolu u diabetiků 2. typu s dyslipidemií léčených maximální tolerovanou dávkou statinů2019 | First Faculty of Medicine
- Combination therapy for dyslipidemia2014 | First Faculty of Medicine
- Patient with acute ischemic stroke2023 | First Faculty of Medicine
- Proprotein convertase subtilisin/kexin type 9 inhibitors in the treatment of a patient with dyslipidemia and myopathy2019 | Third Faculty of Medicine
- Combined hypolipidemic treatment in patients with high cardiovascular (CV) risk +12009 | Faculty of Medicine in Hradec Králové
- Combined hypolipidemic treatment in patients with high cardiovascular (CV) risk2009 | First Faculty of Medicine
- Combined hypolipidemic therapy using statins and fibrates reducing the cardiovascular risk in the patients with atherogenic dyslipidemia2010 | Faculty of Medicine in Hradec Králové
- Hypolipidemic treatment in patients with metabolic syndrome and chronic renal disease.2009 | First Faculty of Medicine
- Extermination of atherosclerosis not only in lower extremities2019 | Second Faculty of Medicine
- Acute myocardial infarction in a male patient with metabolic syndrome and obstructive sleep apnea syndrome2020 | Faculty of Medicine in Pilsen
- Individualized approach in dyslipidemia treatment2015 | Faculty of Medicine in Pilsen
- Status of fibrates in the treatment of patients with high CV risk: the European consensus in 20152016 | First Faculty of Medicine